PML/RARA t(15:17) Quantitative

This test quantifies the PML-RARa fusion gene transcript in blood, which is indicative of acute promyelocytic leukemia (APL). It helps monitor treatment response and disease progression.

Also known asPml Raralpha T(15:17)QuantitativeRtpcr Pml Raralpha T(15:17)Quantitative

Available via

Home Collection, Lab Visit

Contains

4 parameters

Earliest reports in

2 Working Days

Test details

PML/RARA t(15:17) Quantitative Test in Vadodara Overview

Preparations

No special preparations needed

Test included
PML/RARA t(15:17) Quantitative includes 4 parameters

  • Speciment Type
  • Pml Raralpha Long Form
  • Pml Raralpha Variant Form
  • Pml Raralpha Short Form
Frequently Asked Questions

This test identifies a specific genetic translocation found in acute promyelocytic leukemia (APL), helping diagnose and monitor this subtype of leukemia.

It confirms the presence of the PML-RARA fusion gene, essential for accurate diagnosis and treatment planning in APL cases.

A bone marrow or blood sample is analyzed using molecular methods like RT-PCR to detect the PML-RARA transcript quantitatively.

Yes, the quantitative nature of the test helps assess disease burden and monitor remission or relapse during therapy.

A negative result typically indicates the absence of the PML-RARA fusion gene, suggesting the leukemia may not be APL.

Test code

9906

Specimen vol. and vacutainer information
SpecimenVacutainerVolume
Bone MarrowOthers1 ML
Edta Whole BloodLavender Vacutainer3 ML
Others (fx)Others3 ML

Specimen stability information

Bone Marrow, Edta Whole Blood

Collection instructions

Clinical History

Specimen rejection criteria

Test run frequency

Every Day TIME - 10:00

Turn around time

2 Working Days

Performing locations

Department

  • Advanced Molecular Diagnostics R&d

CPT and Loinc codes

PML/RARA t(15:17) Quantitative

5700